Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)

NCT01206309 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT01206309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01206309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Study of Immune Mediated Disorders After Allogeneic Hematopoietic Cell Transplantation (HCT)
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
October 31, 2016
Enrollment
911 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiolitis obliterans, cutaneous sclerosis, graft vs host disease